Result:Weak#Margin squeeze#Cost led
| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 81.27 | 31.8% | 25.6% |
| Total Income | 82.88 | 32.2% | 24.0% |
| Expenditure | 82.39 | 30.7% | 27.6% |
| PBT | 0.48 | 85.3% | 78.8% |
| Net Profit | 0.17 | 91.3% | 90.1% |
| OPM | 1.66% | 0.35pp | 2.47pp |
| NPM | 0.21% | 1.43pp | 2.42pp |
| EPS | 0.00 | 100.0% |
Revenue grew 25.6% but expenses outpaced it, more than halving OPM (4.1%→1.7%) and NPM (2.6%→0.2%), driving a 90% PAT collapse — a clear margin-led deterioration for a chemicals name despite top-line growth.
Informational and educational content only. Not investment advice.